Indusatumab
Indusatumab (5F9 Monoclonal antibody) is a monoclonal antibody against human GUCY2C (Guanylate cyclase 2C). Indusatumab can be used to synthesize ADCs, such as Indusatumab vedotin. Indusatumab can be used in cancer research[1].
Product Specifications
CAS Number
1497400-26-6
Product Name Alternative
5F9 Monoclonal antibody
UNSPSC
12352203
Target
Guanylate Cyclase
Type
Inhibitory Antibodies
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/indusatumab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Indusatumab]
Molecular Weight
(145.206 kDa)
References & Citations
[1]e Goeij BE, et al. New developments for antibody-drug conjugate-based therapeutic approaches. Curr Opin Immunol. 2016 Jun;40:14-23.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
U1699-01D-HRP 100 µL
Uracil DNA Glycosylase, CT (UDG, UNG, Uracil DNA Glycosylase 1, UNG 1, UNG1, UNG-1, Uracil DNA Glycosylase 2, DGU, DKFZp781L1143, HIGM4, UNG15) (HRP) discontinued
Sign In for Pricing
View Details 